Table 2.
Characteristics | Patients with CAD (n = 16) | Healthy Controls (n = 16) | p Value |
---|---|---|---|
Age (years) | 61.5 ± 11.6 | 46.1 ± 10.8 | <0.001 |
Male Gender (X) | 16 | 12 | 0.013 |
Framingham Score | 14.2 ± 7.7 | 8.1 ± 7.9 | 0.016 |
CACS | 518.9 ± 631.6 | 0 | 0.001 |
Systolic Blood Pressure | 129.8 ± 13.9 | 122.5 ± 22.1 | 0.326 |
Type 2 Diabetes (n) | 5 (29%) | 2 (12.5%) | 0.124 |
Dyslipidemia (n) | 11 (65%) | 5 (31%) | 0.029 |
CHF (n) | 1 (6%) | 0 | 0.17 |
Active Smoker (n) | 7 (41%) | 9 (56%) | 0.283 |
Total Cholesterol | 173.2 ± 42.2 | 193.8 ± 45.1 | 0.098 |
LDL-Cholesterol | 98.6 ± 40.5 | 116.4 ± 35.4 | 0.169 |
HDL-Cholesterol | 45.9 ± 15.1 | 37.4 ± 17.7 | 0.075 |
Medications (n) | |||
Antiplatelet | 8 (47%) | 1 (6%) | 0.004 |
β-Blockers | 8 (47%) | 2 (12.5%) | 0.016 |
Stain | 9 (53%) | 8 (50%) | 0.435 |
ACE or ARB | 9 (53%) | 3 (19%) | 0.045 |
Calcium Channel Blocker | 4 (24%) | 2 (12.5%) | 0.214 |
CACS: coronary artery calcium scoring.